Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...
The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
American Renal Management LLC d/b/a Innovative Renal Care (“IRC”) filed a notice of data breach with the Attorney General ...
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...
1d
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
10 effective empty stomach drinks that can help manage kidney health, reduce damage, and improve renal function without the ...
Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...
Nate Robinson, the 11-year NBA veteran who won the league's Slam Dunk Contest three times, revealed on Instagram that he had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback